Ospedale Santa Maria della Misericordia
Udine, Italy
University hospital in Udine
Piazzale Santa Maria della Misericordia, 15, 33100 Udine UD
About Ospedale Santa Maria della Misericordia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
11
National Cancer Institute, Naples
7
Fondazione Italiana Linfomi ONLUS
6
Gruppo Italiano Trapianto di Midollo Osseo
6
Heart Care Foundation
6
Janssen Research & Development, LLC
6
Hoffmann-La Roche
5
Boehringer Ingelheim
4
Boston Scientific Corporation
4
Fondazione Michelangelo
4
Gruppo Italiano Malattie EMatologiche dell'Adulto
4
Clinical Trials at Ospedale Santa Maria della Misericordia
During the past decade, Ospedale Santa Maria della Misericordia conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 39 clinical trials were completed, i.e. on
average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 21 clinical trials were completed. i.e. 95.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
2000-11-01
2016-08-01
Completed
1,086
Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
2000-02-01
Unknown status
300
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2001-09-01
Unknown status
700
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
2004-07-01
2010-07-01
Completed
140
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
2004-09-01
2006-11-01
Terminated
248
A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
2005-11-01
2012-05-01
Completed
124
Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
2005-08-01
2011-12-01
Terminated
77
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ospedale Santa Maria della Misericordia" #1 sponsor was "Celgene" with 11 trials, followed by "National Cancer Institute, Naples" with 7 trials
sponsored, "Fondazione Italiana Linfomi ONLUS" with 6 trials sponsored, "Gruppo Italiano Trapianto di Midollo Osseo" with 6 trials sponsored and "Heart Care Foundation"
with 6 trials sponsored. Other sponsors include 125 different institutions and
companies that sponsored additional 82 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Maria della Misericordia"
#1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Regione Lombardia" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were
collaborators in the rest 53 trials.
Clinical Trials Conditions at Ospedale Santa Maria della Misericordia
According to Clinical.Site data, the most researched conditions in "Ospedale Santa Maria della Misericordia" are
"Multiple Myeloma" (8 trials), "Atrial Fibrillation" (7 trials), "Breast Cancer" (7 trials), "Heart Failure" (6 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Ospedale Santa Maria della Misericordia" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Santa Maria della Misericordia
Most popular intervention types in "Ospedale Santa Maria della Misericordia" are "Drug" (117 trials), "Other" (20 trials), "Device" (16 trials), "Procedure" (12 trials) and "Biological" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Dexamethasone" (8 trials), "Rituximab" (8 trials), "Cyclophosphamide" (6 trials) and "Carboplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Santa Maria della Misericordia
The vast majority of trials in "Ospedale Santa Maria della Misericordia" are
148 trials for "All" genders, 17 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Ospedale Santa Maria della Misericordia
Currently, there are NaN active trials in "Ospedale Santa Maria della Misericordia".
undefined are not yet recruiting,
21 are recruiting,
30 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 76 completed trials in Ospedale Santa Maria della Misericordia,
undefined suspended trials,
and 17 terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Santa Maria della Misericordia, 4 "Phase 1"
clinical trials were conducted, 43 "Phase 2" clinical
trials and 75 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 9 trials that are defined as “Not Applicable".